
1. value health reg issues. 2013 dec;2(3):347-356. doi: 10.1016/j.vhri.2013.10.002. 
epub 2013 dec 12.

dengue epidemiology burden disease latin america caribbean: a
systematic review literature meta-analysis.

cafferata ml(1), bardach a(2), rey-ares l(1), alcaraz a(1), cormick g(1), gibbons
l(1), romano m(1), cesaroni s(1), ruvinsky s(3).

author information: 
(1)institute clinical effectiveness health policy (iecs), buenos aires,
argentina.
(2)institute clinical effectiveness health policy (iecs), buenos aires,
argentina. electronic address: abardach@iecs.org.ar.
(3)infectology department, national pediatric hospital "dr j. p. garrahan,"
buenos aires, argentina.

introduction: dengue virus infection common arthropod-borne disease
worldwide approximately 50 100 million cases dengue infection
occurring annually. globally, dengue incidence increased last 40
years, especially latin american caribbean (lac) countries the
highest incidence found. systematic review aimed present information
on dengue disease burden use health resources lac region the
last 15 years.
methods: searched main international regional databases generic
and academic internet search engines. gray literature retrieved mainly from
regional health ministries pan american health organization. set of
inclusion criteria defined.
results: identified 2,041 articles 25 met criteria, 13 for
incidence 12 use resources related costs. pooled incidence
of classic dengue fever 72.1 cases per 100,000 persons-years 44 lac
countries analyzed (95% confidence interval 71.5-72.7), upward trend from
1995 2010. case-fatality ratio highest 1997 (0.12 [0.05-0.22]) and
lowest 2009, overall mortality 0.02 per 100,000 people. 
60% cases lac region came brazil. length hospital stay 
ranged 5 13 days.
conclusions: activities control dengue transmission region been
important insufficient. surveillance dengue burden disease and
circulating strains help shape evaluate present future health
policies.

Â© 2013 international society pharmacoeconomics outcomes research (ispor) 
published international society pharmacoeconomics outcomes research
(ispor) rights reserved.

doi: 10.1016/j.vhri.2013.10.002 
pmid: 29702769 

